← Eichor
Condition: Advanced Gynecologic Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Advanced Gynecologic Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Exploratory Clinical Study of cCTL in Combination With Immunotherapy for Advanced Gynecologic Malignancies
EARLY_Phase 1 · 1 location(s) · Obstetrics & Gynecology Hospital of Fudan University · NCT07434284First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Parti
Phase 1/Phase 2 · 65 location(s) · Eli Lilly and Company · NCT05768139BOLSTER: Learning New Skills to Thrive
NA · 2 location(s) · Dana-Farber Cancer Institute · NCT06936878Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The Co
Phase 2 · 483 location(s) · National Cancer Institute (NCI) · NCT05564377Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanc
Phase 1 · 12 location(s) · Whitehawk Therapeutics, Inc. · NCT07444814Advanced Pelvic Surgical Oncology Database - Prospective Observational Study
Phase N/A · 1 location(s) · Glasgow Royal Infirmary · NCT05696002Identification of Innovative Biomarkers Related to the Immune System or Tumor Microenvironment to Promote the Efficacy o
NA · 2 location(s) · Centre Hospitalier Universitaire de Besancon · NCT06626269Efficacy and Safety Evaluation of Vi-sealer
NA · 1 location(s) · Hyun Park · NCT05629611A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05787561A Study of GC203 TIL in Advanced Malignant Solid Tumors
Phase 1 · 1 location(s) · Shanghai Juncell Therapeutics · NCT06375187A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT06215950Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Phase 1/Phase 2 · 15 location(s) · Ensem Therapeutics · NCT06993844Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy
Phase N/A · 1 location(s) · Viome · NCT04957511Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART)
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06306170Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel i
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT05092373A Study of GC201 TIL in Advanced Gynecologic Tumors (10hospital)
EARLY_Phase 1 · 1 location(s) · Shanghai Juncell Therapeutics · NCT05098171A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients
Phase 2 · 1 location(s) · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · NCT06522828
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.